Treatment
Treatment A clinical trials
We’re tracking 8,557 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07307456RecruitingPhase 2
Toripalimab and BCG for high-risk bladder cancer
This trial tests a combination of two treatments after bladder tumor surgery: a drug called toripalimab (given through a vein) plus BCG therapy (given into the bladder) for people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this combination can help prevent the cancer from coming back.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07216872Recruiting
Deep TMS to reduce heavy drinking in alcohol use disorder
This trial tests a non-invasive brain stimulation device (Deep TMS) to help people with alcohol use disorder reduce or stop heavy drinking. It uses magnetic pulses to target brain areas linked to addiction.
Tuscaloosa, AlabamaAges 18–86 - NCT07710573Recruiting
Brief PTSD therapy compared to usual care for adults
This study tests a short, focused therapy (SEE FAR CBT) for adults with PTSD. It's a type of talk therapy that helps you process trauma, and the study wants to see if it works better than the usual care you would get.
Sha'ar HanegevAges 18 years+ - NCT07708662Recruiting
Boosted compression for long-term leg swelling
This trial tests a stronger compression method for people with long-lasting leg swelling (edema) that is not caused by another medical condition. The goal is to see if it works better than standard care.
Edegem, AntwerpAges 18 years+ - NCT07707011Enrolling by invitation
Comparing two test-guided treatments for acid reflux
This trial compares two ways to choose the best treatment for people with frequent acid reflux. It tests whether using a simple test (called PCAB-guided) is as good as a more detailed test (called physiologic test-guided) for deciding on the right medicine. The goal is to find a more practical and effective approach.
Bangkok Noi, BangkokAges 18–70 - NCT05422690RecruitingPhase 2
Treating bile duct cancer with chemo plus Y-90 radiation
This Phase 2 study tests whether combining chemotherapy (gemcitabine and cisplatin) and an immunotherapy drug (durvalumab) with targeted Y-90 radiation can shrink inoperable intrahepatic cholangiocarcinoma tumors. It’s looking for better tumor shrinking and improved cancer control.
Fairfax, VirginiaAges 18 years+ - NCT07649525RecruitingPhase 3
Personalized myeloma treatment based on response and fitness
This trial tests whether tailoring myeloma treatment based on how well you respond to initial therapy and your overall health status can improve outcomes. You'll receive standard first-line treatment (three drugs: daratumumab, lenalidomide, and dexamethasone) and then be assigned to a personalized pathway based on your response and fitness level.
BristolAges 18 years+ - NCT02988128Recruiting
Medical device registry for Medtronic neurovascular products
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Buenos AiresAges 18 years+ - NCT03272698RecruitingPhase 4
Ketamine plus ECT versus higher-dose ketamine with rescue
This study compares two ways of using ketamine with ECT (electroconvulsive therapy) in people with treatment-resistant depression. It aims to find whether a higher-dose ketamine approach, with extra rescue measures, works better or more safely.
Saskatoon, SaskatchewanAges 18 years+ - NCT03417622RecruitingPhase 3
Wide vs narrow breast surgery margins after lumpectomy
This study compares two ways of cutting the edge (margin) of tissue during lumpectomy after breast cancer treatment. It may help reduce the chance of the cancer coming back locally by testing whether a wider margin is better than a narrow one.
Al Mansurah, DKAges 18 years+ - NCT03445949RecruitingPhase 4
Best blood-thinner plan after a left heart device procedure
This trial compares which two medicines work best after a device closes off a part of the heart called the left atrial appendage. It may help reduce stroke risk while balancing bleeding risk after your procedure.
Warsaw, Masovian VoivodeshipAges 18 years+ - NCT03457168Recruiting
Testing treatment for high blood pressure during sleep
This study looks at how to manage high blood pressure specifically during sleep, aiming to lower the risk it can cause over time. It may help you if your blood pressure readings stay high at night even if you’re otherwise able to function normally.
Ourense, OrenseAges 18 years+ - NCT03465982Recruiting
Timing surgery after chemotherapy and radiation for rectal cancer
This trial studies the best time to do surgery after you finish chemotherapy and radiation for rectal cancer. It may help improve how well minimally invasive surgery works and how safely it can be done.
Alessandria, ALAges 18 years+ - NCT03517761Recruiting
Bone marrow injection trial for upper neck ligament injuries
This trial studies whether an injection using bone marrow concentrate can help people with specific upper-neck ligament and joint injuries after a trauma. It aims to improve symptoms and disability so you may be able to avoid or delay surgery.
Broomfield, ColoradoAges 18–65 - NCT03522545RecruitingPhase 1
Stem cell add-on for hard-to-treat bipolar depression
This Phase 1 study tests whether adding allogeneic (donor) stem cells to standard care is safe and may help adults with bipolar depression that has not improved with usual treatments. It mainly targets people with more severe symptoms and certain blood inflammation levels.
Houston, TexasAges 18–65 - NCT03537794Recruiting
Brain scan study in depression using a dopamine binding marker
This study uses a special brain imaging scan (PET) to measure how dopamine receptors are binding in people with treatment-resistant depression, compared with healthy volunteers. It aims to better understand brain chemistry differences that may help guide future treatment.
Toronto, OntarioAges 25–55 - NCT03577041Recruiting
Cost study of eye injections for new macular degeneration
This study evaluates the cost-effectiveness of three anti-VEGF eye injection treatments (bevacizumab, ranibizumab, or aflibercept) for patients with newly diagnosed age-related macular degeneration affecting the center of vision. The research aims to understand which treatment option provides the best medical and financial value in France.
AmiensAges 18–70 - NCT03583684Recruiting
Brain scan study to predict response to Pivotal Response Treatment
This study uses brain scans to learn which young children with autism are most likely to improve with Pivotal Response Treatment (PRT). It may help families and clinicians choose the best early treatment based on early brain signals.
Stanford, CaliforniaAges 2–4 - NCT03792919RecruitingPhase 4
Stopping long-term hepatitis B medicine vs continuing
This study compares outcomes for people with chronic hepatitis B who have long-term, stable viral suppression: stopping their antiviral medicine versus continuing it. It may help answer whether it’s safe to stop treatment in the right patients.
Hong Kong, Hong Kong SARAges Any age - NCT03825874Recruiting
Study digestive side effects after antibiotics for UTIs in kids
This study looks at possible effects on a child’s digestive system after standard antibiotics are used to treat a fever-related urinary tract infection (UTI). It may help doctors better understand what side effects to expect and how to manage them.
Charenton-le-PontAges 3 months–3 years - NCT03845205Recruiting
Liver transplant timing study for alcohol-related liver disease
This study compares early versus standard liver transplant timing for people whose liver illness was caused by alcohol use. It looks at treatment outcomes to see which approach helps patients do better.
Baltimore, MarylandAges 18 years+ - NCT03887559Recruiting
Group therapy for long-lasting trauma reactions in everyday clinics
This study tests a structured group program to help people manage long-lasting trauma-related symptoms such as feeling “on edge,” avoiding reminders, upsetting memories, strong emotions, or relationship problems. It may help you learn skills and stabilize symptoms while you continue care through regular outpatient clinics.
TrondheimAges 18–75 - NCT03887481Recruiting
Brain stimulation study for a language-loss dementia subtype
This trial tests whether a painless form of brain stimulation can improve language and thinking skills in people with the logopenic variant of primary progressive aphasia (a dementia that affects language). You may receive brain stimulation along with repeated clinic visits to track changes over time.
Baltimore, MarylandAges 50–80 - NCT03952962Recruiting
Brain stimulation trial for depression that hasn’t improved
This trial tests a targeted deep brain stimulation procedure to reduce symptoms in people with long-lasting, treatment-resistant depression. It may help by improving mood symptoms using stimulation guided by detailed brain imaging.
Dallas, TexasAges 21–70
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,557 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.